Successful Treatments and Management of A Case of Canine Melioidosis
- PMID: 31547534
- PMCID: PMC6958349
- DOI: 10.3390/vetsci6040076
Successful Treatments and Management of A Case of Canine Melioidosis
Abstract
This communication presents a successful story of an attempt to treat and manage a case of canine melioidosis, a severe tropical disease caused by Burkholderia pseudomallei. A 10-year-old dog was trapped with barbed wires, causing an infected wound around its neck and back, which was later diagnosed as severe melioidosis. The dog was treated based on a modified human protocol. Intravenous meropenem injections (20 mg/kg twice daily) were given for 14 days to prevent death from sepsis prior to treatment with oral sulfamethoxazole-trimethoprim (25 mg/kg twice daily) for 20 weeks to eliminate the bacteria. Canine melioidosis is an unusual infection in dogs, even in Thailand where melioidosis is highly endemic. This successful case management was solely based on proper diagnosis and appropriate treatments.
Keywords: Burkholderia pseudomallei; canine melioidosis; meropenem; sulfamethoxazole-trimethoprim.
Conflict of interest statement
The authors declare no conflict of interest. The funder had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures

Similar articles
-
A case report of Tubo-ovarian abscess caused by Burkholderia pseudomallei.BMC Infect Dis. 2018 Feb 8;18(1):73. doi: 10.1186/s12879-018-2986-z. BMC Infect Dis. 2018. PMID: 29422033 Free PMC article.
-
Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.Int J Antimicrob Agents. 2014 Aug;44(2):160-2. doi: 10.1016/j.ijantimicag.2014.04.012. Epub 2014 May 28. Int J Antimicrob Agents. 2014. PMID: 24924662
-
Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method.J Glob Antimicrob Resist. 2017 Sep;10:291-294. doi: 10.1016/j.jgar.2017.04.012. Epub 2017 Jul 18. J Glob Antimicrob Resist. 2017. PMID: 28729203
-
Melioidosis in a patient with chronic rhinosinusitis.J Laryngol Otol. 2016 Jul;130 Suppl 4:S60-2. doi: 10.1017/S0022215116008276. J Laryngol Otol. 2016. PMID: 27488340 Review.
-
Infective myositis, an uncommon presentation of melioidosis: a case report and review of the literature.J Med Case Rep. 2019 Dec 31;13(1):388. doi: 10.1186/s13256-019-2321-3. J Med Case Rep. 2019. PMID: 31888746 Free PMC article. Review.
Cited by
-
A molecular epidemiological analysis of Burkholderia pseudomallei in southern Thailand.PLoS Negl Trop Dis. 2024 Aug 22;18(8):e0012444. doi: 10.1371/journal.pntd.0012444. eCollection 2024 Aug. PLoS Negl Trop Dis. 2024. PMID: 39173078 Free PMC article.
-
Seroprevalence of melioidosis and its association with blood profiles and pathogens in sheltered dogs in southern Thailand.Vet World. 2024 Mar;17(3):705-711. doi: 10.14202/vetworld.2024.705-711. Epub 2024 Mar 25. Vet World. 2024. PMID: 38680143 Free PMC article.
References
-
- Limmathurotsakul D., Dance D.A., Wuthiekanun V., Kaestli M., Mayo M., Warner J., Wagner D.M., Tuanyok A., Wertheim H., Yoke Cheng T., et al. Systematic review and consensus guidelines for environmental sampling of Burkholderia pseudomallei. PLoS Negl. Trop. Dis. 2013;7:e2105. doi: 10.1371/journal.pntd.0002105. - DOI - PMC - PubMed
-
- Godoy D., Randle G., Simpson A.J., Aanensen D.M., Pitt T.L., Kinoshita R., Spratt B.G. Multilocus Sequence Typing and Evolutionary Relationships among the Causative Agents of Melioidosis and Glanders, Burkholderia pseudomallei and Burkholderia mallei. J. Clin. Microbiol. 2003;41:2068–2079. doi: 10.1128/JCM.41.5.2068-2079.2003. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources